China SXT Pharmaceuticals Inc
SXTC
Closed
$4.04
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
Key stats
Open
$4.26
Volume
3.00M
Market cap
$5.42M
Prev. close
$4.09
Impl / hst vl
-
Open interest
$0.00
$3.65
Day’s Range
$6.00
$0.03
52W Range
$6.98
Valuation
55
Valuation score
Fairly Valued
P/E
-
P/S
3.79
P/B
0.15
Current ratio
7.93
Debt / Equity
0.03
ROE
-24.85%
Gross margin
28.74%
Income growth
-102.57%
FCF growth
100.60
Analysts estimates
Earnings
Q1 ‘26 revenue
$511.50K
Q1 ‘26 net income
$163.70K
Revenue
Net income
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply